A

Auregen BioTherapeutics

18 employees

Auregen BioTherapeutics provides 3D bioprinting technology for innovative treatments to cure rare disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
3D Technology
Medical

Date founded

2016

Funding rounds raised

A

Auregen BioTherapeutics raised undisclosed on December 1, 2016

Investors: Gurnet Point Capital

FAQ